/Companies

Immune

Boston, US · Founded 2023 · Delaware corporation · 1 known investors

Find your way into Immune

Sign up to see every warm intro you have to Immune

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Immune team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AT
Ariana ThackerNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7.4M disclosed across 2 rounds · 2025

▶$6.4MraisedFeb 2025 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ariana ThackerExecutive Officer
Offering amount
$7M
Amount sold
$6.4M
Minimum investment
$998
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedFeb 2025 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ariana ThackerExecutive Officer
Offering amount
$1M
Amount sold
$1M
Minimum investment
$1K
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Immune's investors?
Immune's investors include BioAdvance.
How much funding has Immune raised?
Immune has disclosed $7.4M raised across 2 rounds.
Where is Immune headquartered?
Immune is headquartered in Boston, US.